BDSX

Biodesix, Inc. BDSX

BDSX
Biodesix, Inc. VNRX
VolitionRx Limited NOTV
Inotiv, Inc. WGRX
Wellgistics Health, Inc. XLO
Xilio Therapeutics, Inc. SKYE
Skye Bioscience, Inc. INMB
INmune Bio, Inc. MRSN
Mersana Therapeutics, Inc. ALGS
Aligos Therapeutics, Inc. OKUR
OnKure Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BDSX VNRX NOTV WGRX XLO SKYE INMB MRSN ALGS OKUR
6M 28.62 % -60.16 % -70.20 % -60.75 % -1.60 % -53.28 % -74.86 % 226.97 % 23.89 % 28.51 %
YTD -76.01 % -57.56 % -84.57 % -87.43 % -39.25 % -64.92 % -63.08 % -16.86 % -73.96 % -63.50 %
1Y -73.51 % -55.87 % -83.63 % -87.43 % -24.99 % -66.78 % -60.18 % -31.12 % -68.59 % -63.88 %
3Y -80.28 % -88.22 % -83.59 % -87.43 % -68.60 % -69.23 % -75.44 % -79.54 % -58.93 % -86.77 %
5Y -97.80 % -93.46 % -92.42 % -87.43 % -95.94 % -92.73 % -82.19 % -95.47 % -98.38 % -97.93 %
10Y -97.23 % -93.71 % -58.82 % -87.43 % -95.94 % -99.43 % -77.22 % -91.69 % -97.21 % -97.93 %
From the beginning -97.23 % -91.09 % -92.16 % -87.43 % -95.94 % -99.96 % -77.22 % -91.69 % -97.21 % -97.93 %

Dividend